Guardant Health (NASDAQ: GH) reported Q3 EPS of ($1.18), $0.21 better than the analyst estimate of ($1.39). Revenue for the quarter came in at $117.4 million versus the consensus estimate of $118.08 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.